Skip to content

Application of man-machine coupling innovative technology in secondary prevention management of patients with coronary heart disease after PCI

Construction and application of dynamic individualized out-of-hospital management system for coronary heart disease after PCI based on man-machine cooperation technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065344
Enrollment
Unknown
Registered
2022-11-02
Start date
2022-11-04
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

1:Conventional secondary prevention of coronary heart disease after PCI + artificial intelligence management system for chronic coronary heart disease
2:Conventional secondary prevention of coronary heart disease after PCI

Sponsors

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-79 years (including boundary value), regardless of gender; 2. Patients with clinical manifestations consistent with coronary heart disease and successfully treated with PCI 3. Agree to participate in the trial, and can adhere to follow-up, go to the hospital on their own; sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Inability to use intelligent management system; 2. NYHA cardiac function grade IV; 3. Unstable condition or complications after percutaneous coronary intervention (PCI) during hospitalization; 4. Cardiovascular and cerebrovascular diseases such as stroke, heart failure and severe arrhythmias (high atrioventricular block, ventricular tachycardia) within 3 months; 5. Chronic renal insufficiency (creatinine > 265 umol/L). 6. Women who are pregnant or breastfeeding; 7. Complicated with other diseases that are not suitable to participate in the trial, such as thyroid diseases, acute infectious diseases, mental and psychological diseases, and a history of tumor diseases within 5 years; 8. The spouse has participated in the study

Design outcomes

Primary

MeasureTime frame
a composite of major adverse cardiac or cerebral events;

Secondary

MeasureTime frame
Incidence of bleeding events during follow-up;Target rate of blood pressure control in patients;

Countries

China

Contacts

Public ContactXiaofan Yu

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

501183943@qq.com+86 13365741273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026